Information Journal Paper
APA:
Copy. (2020). Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. CELL, 181(4), 0-0. SID. https://sid.ir/paper/775699/en
Vancouver:
Copy. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. CELL[Internet]. 2020;181(4):0-0. Available from: https://sid.ir/paper/775699/en
IEEE:
Copy, “Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2,” CELL, vol. 181, no. 4, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/775699/en